Trident Texofab Ltd — Important, 02-07-2026: Company Update

Trident Texofab's Board has approved the forfeiture of 9,11,479 fully convertible warrants. These warrants were not exercised by holders within the prescribed 18-month period. Consequently, the upfront subscription money totaling ₹1.59 crore, paid for these lapsed warrants, has been forfeited by the company. This action results in no change to the company's issued, subscribed, or paid-up equity share capital, as no new shares were issued from these particular warrants, simplifying the capital structure.